Literature DB >> 7219049

Anticancer drug testing in vitro: use of an activating system with the human tumor stem cell assay.

M M Lieber, M M Ames, G Powis, J S Kovach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7219049     DOI： 10.1016/0024-3205(81)90735-9

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  5 in total

1.  Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.

Authors:  D S Alberts; S E Salmon; H S Chen; T E Moon; L Young; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).

Authors:  D S Alberts; J G Einspahr; R Struck; G Bignami; L Young; E A Surwit; S E Salmon
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

3.  Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Authors:  T H Corbett; M C Bissery; A Wozniak; J Plowman; L Polin; E Tapazoglou; J Dieckman; F Valeriote
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

Review 4.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  In vivo and in vitro metabolism of the new anticancer drug bisantrene.

Authors:  Y M Peng; D S Alberts; T P Davis
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.